{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:05:50Z","timestamp":1759341950523},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,1,2]]},"DOI":"10.18632\/oncotarget.19374","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T17:22:33Z","timestamp":1500484953000},"page":"268-281","source":"Crossref","is-referenced-by-count":5,"title":["Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent"],"prefix":"10.18632","volume":"9","author":[{"given":"Haimei","family":"Zhu","sequence":"first","affiliation":[{"name":"College of Pharmaceutical Sciences of Capital Medical University, Beijing, China"},{"name":"Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China"},{"name":"Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences of Capital Medical University, Beijing, China"},{"name":"Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China"},{"name":"Beijing Laboratory of Biomedical Materials, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ce","family":"Song","sequence":"additional","affiliation":[{"name":"Guangxi Pusen Biotechnology Co. Ltd., Guilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiqi","family":"Feng","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences of Capital Medical University, Beijing, China"},{"name":"Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China"},{"name":"Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Wu","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences of Capital Medical University, Beijing, China"},{"name":"Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China"},{"name":"Beijing Laboratory of Biomedical Materials, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shurui","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences of Capital Medical University, Beijing, China"},{"name":"Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China"},{"name":"Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Gui","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences of Capital Medical University, Beijing, China"},{"name":"Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China"},{"name":"Beijing Laboratory of Biomedical Materials, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences of Capital Medical University, Beijing, China"},{"name":"Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China"},{"name":"Beijing Laboratory of Biomedical Materials, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences of Capital Medical University, Beijing, China"},{"name":"Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China"},{"name":"Beijing Laboratory of Biomedical Materials, Beijing, China"},{"name":"Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqi","family":"Peng","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences of Capital Medical University, Beijing, China"},{"name":"Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, China"},{"name":"Beijing Laboratory of Biomedical Materials, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.lfs.2015.02.025","article-title":"P-selectin enhances growth and metastasis of mouse mammary tumors by promoting regulatory T cell infiltration into the tumors","volume":"131","author":"Yusuf","year":"2015","journal-title":"Life Sci"},{"key":"2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ajpath.2012.10.026","article-title":"Angiotensin II type 1A receptor signaling facilitates tumor metastasis formation through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells","volume":"182","author":"Majima","year":"2013","journal-title":"American Journal of Pathology"},{"key":"3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.atherosclerosis.2015.01.022","article-title":"Soluble P-selectin predicts lower extremity peripheral artery disease incidence and change in the ankle brachial index: The Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"239","author":"Bielinski","year":"2015","journal-title":"Atherosclerosis"},{"key":"4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2015.02.036","article-title":"P-Selectin and subclinical and clinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"240","author":"Polak","year":"2015","journal-title":"Atherosclerosis"},{"key":"5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.fertnstert.2015.01.001","article-title":"P-selectin as a potential therapeutic target for endometriosis","volume":"103","author":"Liu","year":"2015","journal-title":"Fertil Steril"},{"key":"6","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.jacc.2013.03.004","article-title":"Targeting P-selectin during coronary interventions: The elusive link between inflammation and platelets to prevent myocardial damage","volume":"61","author":"Angiolillo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.carbpol.2014.01.039","article-title":"Inhibition of inflammatory injure by polysaccharides from Bupleurum chinense through antagonizing P-selectin","volume":"105","author":"Sun","year":"2014","journal-title":"Carbohydr Polym"},{"key":"8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1039\/C5MD00507H","article-title":"Design, synthesis and evaluation of a novel pi-pi stacking nano-intercalator as an anti-tumor agent","volume":"7","author":"Peng","year":"2016","journal-title":"Med Chem Comm"},{"key":"9","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1021\/jm901816j","article-title":"A class of 3S-2-aminoacyltetrahydro-beta-carboline-3-carboxylic acids: Their facile synthesis, inhibition for platelet activation, and highanti-thrombotic potency","volume":"53","author":"Peng","year":"2010","journal-title":"J Med Chem"},{"key":"10","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1016\/j.bmc.2007.06.012","article-title":"A new class of anti-thrombosis hexahydropyrazino-[1\u2032,2\u2032:1,6]pyrido[3,4-b]indole-1,4-dions: Design, synthesis, log K determination, and QSAR analysis","volume":"15","author":"Peng","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"11","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1016\/j.ejmech.2011.04.037","article-title":"A class of oral N-[(1S,3S)-1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carbonyl]-N\u2019-(amino-acid-acyl)hydrazine: Discovery, synthesis,anti-platelet aggregation\/anti-thrombotic evaluation and 3D QSAR analysis","volume":"46","author":"Peng","year":"2011","journal-title":"Eur J Med Chem"},{"key":"12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0960-894X(01)00809-5","article-title":"Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence","volume":"12","author":"Peng","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"13","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1016\/j.bmc.2007.08.061","article-title":"Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA\/Dx5 cell assay, and SAR of benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3\u2032,4\u2032:1,2]pyridin[3,4-b]indol-2-substitutedacetates","volume":"15","author":"Peng","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"14","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1016\/j.ejmech.2009.05.006","article-title":"Novel N-(3-carboxyl-9-benzyl-beta-carboline-1-yl)ethylamino acids: Synthesis, anti-tumor evaluation, intercalating determination, 3D QSAR analysis and docking investigation","volume":"44","author":"Peng","year":"2009","journal-title":"Eur J Med Chem"},{"key":"15","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1016\/j.bmc.2010.07.043","article-title":"A class of novel carboline intercalators: Their synthesis,anti-proliferation,anti-tumor action, and 3D QSAR analysis","volume":"18","author":"Peng","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"16","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.bmc.2010.01.038","article-title":"Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3\u2032,4\u2032:1,2]pyridine- [3,4-b]indole-2-substituted acetates: One-pot-preparation, anti-tumor activity, docking toward DNA and 3D QSAR analysis","volume":"18","author":"Peng","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"17","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1016\/j.bmc.2006.06.021","article-title":"Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates","volume":"14","author":"Peng","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1039\/c3md00004d","article-title":"Energy minimized crystal structures of P-selectins based on molecular dynamics simulation: leading to two average structures capable of designing anti-thrombotic agents","volume":"4","author":"Peng","year":"2013","journal-title":"Med Chem Comm"},{"key":"19","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1039\/C6TB00874G","article-title":"DHDMIQK(KAP): a novel nano-delivery system of dihydroxyltetrahydro-isoquinoline-3-carboxylic acid and KPAK towards the thrombus","volume":"4","author":"Peng","year":"2016","journal-title":"J Mater Chem B"},{"key":"20","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.2147\/IJN.S88052","article-title":"Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis","volume":"10","author":"Peng","year":"2015","journal-title":"Int J Nanomedicine"},{"key":"21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0049-3848(03)00339-6","article-title":"Anti-thrombotic activity of PDR, a newly synthesized L-Arg derivative, on three thrombosis models in rats","volume":"110","author":"Peng","year":"2003","journal-title":"Thromb Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2147\/DDDT.S113804","article-title":"Nanomedical strategy to prolong survival period, height encure rate and lower systemic toxicity of S180 mice treated with MTX\/MIT","volume":"10","author":"Peng","year":"2016","journal-title":"Drug Des Dev Ther"},{"key":"23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jff.2016.09.013","article-title":"Dysfunction of aorta is prevented by whey protein concentrate-80 in venous thrombosis-induced rats","volume":"27","author":"Car","year":"2016","journal-title":"J Funct Foods"},{"key":"24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2015.08.022","article-title":"Elevated baseline plasma IL-8 levels are an independent predictor of long-term all-cause mortality in patients with acute coronary syndrome","volume":"242","author":"Eng","year":"2015","journal-title":"Atherosclerosis"},{"key":"25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cyto.2015.12.023","article-title":"Significant hepatic expression of IL-2 and IL-8 in biliary atresia compared with other neonatal cholestatic disorders","volume":"79","author":"Sira","year":"2016","journal-title":"Cytokine"},{"key":"26","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1039\/C6MD00215C","article-title":"Design, synthesis, andevaluations of benzyl N-omega-nitro-N-alpha-(9H-pyrido[3,4-b]indole-3-carbonyl)-L-argininate as an apoptosis inducer capable of decreasing the serum concentration of P-selectin","volume":"7","author":"Peng","year":"2016","journal-title":"Med Chem Comm"},{"key":"27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.imlet.2011.11.003","article-title":"C1q regulates collagen-dependent production of reactive oxygen species, aggregation and levels of soluble P-selectin in whole blood","volume":"142","author":"Bengtsson","year":"2012","journal-title":"Immunol Lett"},{"key":"28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.surg.2011.09.045","article-title":"Radiation-induced platelet-endothelial cell interactions are mediated by P-selectin and P-selectin glycoprotein ligand-1 in the colonic microcirculation","volume":"151","author":"Thorlacius","year":"2012","journal-title":"Surgery"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed","article-title":"Redox regulation of cardiovascular inflammation-Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species","author":"Daiber","year":"2017","journal-title":"Free Radical Bio Med"},{"key":"30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jdermsci.2011.07.005","article-title":"The roles of P- and E-selectins and P-selectin glycoprotein ligand-1 in primary and metastatic mouse melanomas","volume":"64","author":"Sato","year":"2011","journal-title":"J Dermatol Sci"},{"key":"31","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.05.005","article-title":"Early dynamics of P-selectin and interleukin 6 predicts outcomes in ischemic stroke","volume":"24","author":"Illes","year":"2015","journal-title":"J Stroke Cerebrovasc"},{"key":"32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jtice.2011.07.008","article-title":"Inhibition of P-selectin-mediated inflammation cell adhesion by 6SCM-chitin","volume":"43","author":"Zeng","year":"2012","journal-title":"J Taiwan Inst Chem E"},{"key":"33","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1039\/C6TB02705A","article-title":"IQCA-TASS: a nano-scaled P-selectin inhibitor capable of targeting thrombus and releasing IQCA\/TARGD(S)S","volume":"5","author":"Peng","year":"2017","journal-title":"J Mater Chem B"},{"key":"34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.thromres.2013.02.020","article-title":"Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab\u2014preclinical and clinical studies","volume":"131","author":"Schmitt","year":"2013","journal-title":"Thromb Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2015.10.018","article-title":"Thrombin-induced IL-8\/CXCL8 release is mediated by CK2, MSK1, and NF-kappaB pathways in human lung epithelial cells","volume":"767","author":"Chen","year":"2015","journal-title":"Eur J Pharmacol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:57:37Z","timestamp":1589018257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,2]]}},"alternative-id":["19374","29416612"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.19374","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]}}}